BLOGS: (11) Questions ANSWERED Top 11 Current

New Post Public Reply Private Reply Replies (0) Message Board
speckulater
BLOGS: (11) Questions ANSWERED




Top 11 Current Shareholders Questions ANSWERED








Hannover House Investor Relations Blog


Friday June 21, 2013

Q&A on multiple issues from HHSE Shareholders... 


Greetings HHSE Friends & Shareholders. Over the past two weeks, we have received a high volume of emails and inquiries from Shareholders, friends and followers with some questions recurring and needing to be addressed. Listed below are the top 10 (Actually 11, #7 is Duplicated) current questions for HHSE management, and the answers as to their status, etc... 



1). Are the Q1 results ever going to be released?

A: Yes, promptly.



2). Will the release of Q1 results enable the OTC Markets "Yield" sign to be removed from the stock listing?

A: Yes.



3). Is the company ever going to release two-years of financial audits so that the stock can become fully reporting? 

A: Yes, and as required for Edgar / SEC status (and Form 10 acceptance) the two years of audits must be the "two most recent" years, which in our case are 2011 and 2012. The company had previously completed all worksheets and backup for 2010 and 2011; but for 2012, there are still some items requiring backup support or third party verifications (which are in process and almost complete). Under the TCA credit agreement, the company is required to have these audits completed and posted quickly, and we see no impediments to satisfying this requirement. As a Pinksheet OTC-Markets security, HHSE has not been required to complete audits, even though it has been a corporate goal for the past two years. Now, however, the completion of audits is required for compliance with the Company's senior lender, and as such, must become top priority.



4). Is the Film Library value the cause of audit delays?

A: No. The value of the Company's Film Library is not under question or review. The Film Library is one of the audit items already fully addressed during the past two-years (approx.) that the Company has been working with auditors on this project. The current audit issues (relating to the 2012 year-end) are customary items of back-up review, third-party verifications and analysis of capitalized items relative to ultimate revenues. 



5). What's the update on "Mother Goose"? How can HHSE finance a $12-mm production when the Company is otherwise tightly managing cash flow?

A: There's a lot of exciting activities happening with this production, from distribution partnerships and presales, to an amazing cast of box-office superstars. HHSE is not "financing" the movie with existing credit lines, cash flow or debt. The film is being financed primarily through a bank structure that includes a direct assignment of international presales, tax incentives, rebates and a senior lien on the asset and revenue streams. The announcement of distribution partners will be withheld until its deemed most beneficial for the partners (perhaps timed for a major festival or market, or timed to correspond with a theatrical and network broadcast debut of the first teaser-trailer). The announcement of cast members will be subject to the approval of the agents, managers and publicists for the principal stars, as required. 




6). Is HHSE involved with the new Terminator 5 feature production?

A: No. But the Company has continued to develop the T3K ("Terminator 3000") concept for an animated feature, which would be a complementary and supporting title to the T5 project.



7). Is the Company still pursuing "higher-profile" titles, or is the business model now strictly indie films for the direct-to-video / VOD market?

A: The "meat-and-potatoes" business model for the Company at present is to acquire and release easily placed films for DVD and VOD, while pursuing "tent-pole" / event-level releases to drive the visibility and revenues for each year. The direct-to-video titles are highly profitable with great return-on-investment (i.e., an average upfront cost of $10,000 plus replication & freight can predictably return $150,000 to $250,000 in gross sales per title). However, there is a revenue-limit to this model in that the Company's key accounts usually cannot absorb more than two (possibly three) new titles from an indie studio like Hannover House per month. So for the Company to break a respectable revenue goal of $50-million per year, one or more titles like "Mother Goose" would be required to generate these front-line / mainstream results. 



7.5). Why has there been such a heavy volume of "short" sales in the stock the past three days (approx. 2,106,112 shares)?

A: There are some traders that would like to control the HHSE share price through misinformation and fear. We think that their efforts cannot be sustained against the wave of pressure that the Company's back-log of information and activities is now beginning to generate. It would not take very much buying pressure to force the short squeeze and chase them away to other equities. 



8). What are the terms of the deal and relationship between Hannover House and Nanotech (NTEK) regarding the VODwiz.com Video-On-Demand site and Roku IPTV Channel?

A: NTEK is handling the technical and operational infrastructure for both streaming outlets, with Hannover House acquiring and accumulating programming (both from our own library as well as from a long-list of supplier partners and studios). There is a revenue split agreement with NTEK. Hannover determined that the upfront costs (both in terms of technical infrastructure and engineering expertise) were significant, and instead agreed to the NTEK deal to enable HHSE to focus on the programming and not the hardware. Additional details will be released under mutually approved announcements. 



9). Is the Company still involved with book publishing? There haven't been any new releases in a long while.

A: Yes, new publishing activities are in place now, even though prior plans for 2012 were delayed. "ONE OF THE LUCKY ONES" ships from the printer today, and will hit book stores next month. "SABLE SHORE" and "BLIND VISION" will print next week for August on-sale dates. All three items will be widely available on e-Book formats. The Company temporarily stopped new release activities of publishing projects in 2012 due to uncertainty in the marketplace. The Company's largest book retail customer, Borders Group, Inc., went completely out of business, and sales to the Company's primary book wholesaler, NBN Books, ground to a halt. With e-Books emerging as the dominant media, Hannover decided to wait-and-see before investing in large print runs or promotions. The Company is now comfortable with a strategy of modest print runs and a more aggressive effort to develop the e-Book formats.



10). How come I couldn't find "Toys in the Attic" at some Wal-Mart locations?

A: In January of this year, the Company's relationship with the Vendor-Manager / distribution partner that had been placing our products into Wal-Mart deteriorated over a sales and cash dispute; a prior agreement for this vendor to remit monthly payments to Hannover House, as well as an agreement for direct payment to the replication lab, were both ignored by this distribution partner. These actions caused a disruption in the product flow and nationwide roll-out of units to Wal-Mart on the initial street date. The dispute with this former distribution partner continues, and may result in litigation by Hannover House with our Company's demand that they render payment. Accordingly, HH would be remiss to publicly release additional details at this time. Hannover House has since replaced this former distribution partner with a much larger entity with greater placement strength and higher per-unit net pricing to Hannover House. This new distribution relationship is one of the exciting and pending new announcements for the Company.


* * * * * 

Address your Shareholder questions to: HannoverPR@aol.com / Thanks!




There are Two (2) New BLOG Posts on the Hannover House (HHSE) Investor Relations Blog: 

Friday June 21, 2013 


Top 11 Current Shareholders Questions ANSWERED:

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 10

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Runway Growth Acquires SWK Holdings in Major Merger Deal

Updated Category News Views 292

Runway Growth Announces Acquisition of SWK Holdings Runway Growth Finance Corp. (NASDAQ: RWAY) has made a significant move by announcing its acquisition of SWK Holdings Corporation (NASDAQ: SWKH). This strategic deal, valued at around $220 million, reflects Runway's ambition to enhance its investment portfolio. Details of the Acquisition Deal The acquisition will be...

Continue Reading
Generative AI Market for Software and Coding Set for Growth

Updated Category News Views 149

Overview of the Generative AI Market The Generative AI in Software and Coding market is on a promising trajectory, with projections indicating a remarkable increase from USD 31.6 million by 2024 to USD 243.7 million by 2033, a CAGR of 25.5%. This growth reflects the rise of AI technologies capable of automating code generation and software development, streamlining...

Continue Reading
Explore NebulaGraph Cloud: Affordable Beta Access Awaits

Updated Category News Views 77

NebulaGraph Cloud Beta Preview on AWS Global We’re launching the beta preview of NebulaGraph Cloud on AWS Global, and you can try it for up to $1 for a full month. Starting now through the end of November, you can explore a highly scalable, high?performance graph database without a big upfront commitment. Spin it up, kick the tires, and see how it fits your workload....

Continue Reading
Exploring Gold's Surge: Implications for GoldHaven Resources

Updated Category News Views 198

Gold Prices Rise Amid Economic Turmoil Gold prices have experienced a remarkable rise, surging over 25% since the start of the year and stabilizing near the $4,000 per ounce mark. This increase is driven by a wave of investors looking for safe-haven assets amidst persistent inflation and economic uncertainty. Central banks have noticeably been boosting their gold...

Continue Reading
Illinois Tool Works Adjusts Earnings Outlook Amid Observer Changes

Updated Category News Views 237

Illinois Tool Works Inc. Announcements Following Q3 Results Illinois Tool Works Inc. (NYSE: ITW) recently released its third-quarter results for fiscal 2025, showcasing a mix of performance metrics that caught the interest of analysts and investors alike. The company reported a revenue increase of 2.3% year-over-year, amounting to $4.06 billion. However, this result fell...

Continue Reading